30 articles, transcripts, and reports
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice President and Chief…
AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice President and…
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice President and Chief…
AngioDynamics Inc. (NASDAQ: ANGO) Q2 2021 earnings call dated Jan. 07, 2021 Corporate Participants: Jim Clemmer — President and Chief Executive Stephen A. Trowbridge — Executive Vice President and…
AngioDynamics Inc. (NASDAQ: ANGO) Q1 2021 earnings call dated Sep. 29, 2020 Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice President…
AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today. Net sales increased 6.3% to $70.2 million but were impacted by the disruption to…
AngioDynamics, Inc. (NASDAQ: ANGO) Q4 2020 earnings call dated July 16, 2020 Corporate Participants: Jim Clemmer — President and Chief Executive Officer Stephen A. Trowbridge — Executive Vice President…
AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss for the fourth quarter was…
AngioDynamics Inc (ANGO) Q2 2020 earnings call dated Jan. 07, 2020 Corporate Participants: Jim Clemmer — President, Chief Executive Officer, Director Steve Trowbridge — Senior Vice President, General Counsel…
— AngioDynamics Inc. (NASDAQ: ANGO) reported Q2 2020 earnings of $0.06 per share, vs. $0.02 expected. — Net sales remained flat at $70 million, vs.…
